- Home
- KVUE vs IR Comparison
KVUE vs IR Comparison
Compare KVUE & IR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVUE
- IR
- Stock Information
- Founded
- KVUE 2022
- IR 1859
- Country
- KVUE United States
- IR United States
- Employees
- KVUE N/A
- IR N/A
- Industry
- KVUE Specialty Chemicals
- IR Industrial Machinery/Components
- Sector
- KVUE Consumer Discretionary
- IR Industrials
- Exchange
- KVUE Nasdaq
- IR Nasdaq
- Market Cap
- KVUE 41.0B
- IR 35.1B
- IPO Year
- KVUE 2023
- IR N/A
- Fundamental
- Price
- KVUE $21.26
- IR $76.41
- Analyst Decision
- KVUE Buy
- IR Buy
- Analyst Count
- KVUE 12
- IR 10
- Target Price
- KVUE $24.38
- IR $99.90
- AVG Volume (30 Days)
- KVUE 21.6M
- IR 3.5M
- Earning Date
- KVUE 08-07-2025
- IR 07-31-2025
- Dividend Yield
- KVUE 3.84%
- IR 0.11%
- EPS Growth
- KVUE 28.77
- IR N/A
- EPS
- KVUE 0.74
- IR 1.29
- Revenue
- KVUE $15,141,000,000.00
- IR $7,364,300,000.00
- Revenue This Year
- KVUE $2.34
- IR $6.90
- Revenue Next Year
- KVUE $3.56
- IR $4.94
- P/E Ratio
- KVUE $28.83
- IR $58.73
- Revenue Growth
- KVUE N/A
- IR 4.67
- 52 Week Low
- KVUE $19.75
- IR $65.61
- 52 Week High
- KVUE $25.17
- IR $106.03
- Technical
- Relative Strength Index (RSI)
- KVUE 41.14
- IR 33.29
- Support Level
- KVUE $20.96
- IR $75.69
- Resistance Level
- KVUE $21.96
- IR $88.67
- Average True Range (ATR)
- KVUE 0.57
- IR 1.93
- MACD
- KVUE -0.10
- IR -1.15
- Stochastic Oscillator
- KVUE 4.96
- IR 13.89
About KVUE Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
About IR Ingersoll Rand Inc.
Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $7.2 billion in revenue in 2024.